Publication Results

Generate Report

Add publications by marking their checkboxes, or

Liquid biopsy: a holy grail for cancer detection.

Sorbara L,  Srivastava S
Biomark Med 2019 Aug;13(12):991-994
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31464153
PMC ID: not available

Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.

He HJ,  Stein EV,  Konigshofer Y,  Forbes T,  Tomson FL,  Garlick R,  Yamada E,  Godfrey T,  Abe T,  Tamura K,  Borges M,  Goggins M,  Elmore S,  Gulley ML,  Larson JL,  Ringel L,  Haynes BC,  Karlovich C,  Williams PM,  Garnett A,  StÃ¥hlberg A,  Filges S,  Sorbara L,  Young MR,  Srivastava S,  Cole KD
J Mol Diagn 2019 Jul;21(4):658-676
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31055023
PMC ID: PMC6626992

Cancer overdiagnosis: a biological challenge and clinical dilemma.

Srivastava S,  Koay EJ,  Borowsky AD,  De Marzo AM,  Ghosh S,  Wagner PD,  Kramer BS
Nat Rev Cancer 2019 Jun;19(6):349-358
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31024081
PMC ID: not available

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities (vol 4, pg 523, 2018)

Srivastava Sudhir,  Ghosh Sharmistha,  Kagan Jacob,  Mazurchuk Richard,  Boja Emily,  Ossandon Miguel,  Chuaqui Rodrigo,  Rosenfield Sonia,  Chavarria-Johnson Eric,  Samimi Goli,  Davidsen Tanja,  Shern Jack,  Eary Janet,  Star Rob,  Haim Todd,  Takebe Naoko,  Hanlon Sean,  Tavares Norbert,  Hewitt Stephen,  Tricoli James,  Hughes Shannon,  Trimble Ted,  Jacobs Paula,  Umar Asad,  Li Jerry,  Velazquez Jose,  Lively Tracy,  Wang Chiayeng,  Lockett Stephen,  Zenklusen J. C.,  Misteli Tom,  Oberdoerffer Philipp,  Nelson Stefanie,  Lee Jerry,  Odeh Hana,  Kenney Nicholas
Trends Cancer 2019 Apr;5(4):263-263
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: not available
PMC ID: not available

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Yang JD,  Addissie BD,  Mara KC,  Harmsen WS,  Dai J,  Zhang N,  Wongjarupong N,  Ali HM,  Ali HA,  Hassan FA,  Lavu S,  Cvinar JL,  Giama NH,  Moser CD,  Miyabe K,  Allotey LK,  Algeciras-Schimnich A,  Theobald JP,  Ward MM,  Nguyen MH,  Befeler AS,  Reddy KR,  Schwartz M,  Harnois DM,  Yamada H,  Srivastava S,  Rinaudo JA,  Gores GJ,  Feng Z,  Marrero JA,  Roberts LR
Cancer Epidemiol Biomarkers Prev 2019 Mar;28(3):531-538
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30464023
PMC ID: PMC6401221

Carrier-Assisted Single-Tube Processing Approach for Targeted Proteomics Analysis of Low Numbers of Mammalian Cells.

Zhang P,  Gaffrey MJ,  Zhu Y,  Chrisler WB,  Fillmore TL,  Yi L,  Nicora CD,  Zhang T,  Wu H,  Jacobs J,  Tang K,  Kagan J,  Srivastava S,  Rodland KD,  Qian WJ,  Smith RD,  Liu T,  Wiley HS,  Shi T
Anal Chem 2019 Jan 15;91(2):1441-1451
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30557009
PMC ID: PMC6555634

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.

Borges KA,  Dai J,  Parikh ND,  Schwartz M,  Nguyen MH,  Roberts LR,  Befeler AS,  Srivastava S,  Rinaudo JA,  Feng Z,  Marrero JA,  Reddy KR
Contemp Clin Trials 2019 Jan;76:49-54
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30439517
PMC ID: PMC7086481

Validation of a novel model for the early detection of hepatocellular carcinoma.

Hemken PM,  Sokoll LJ,  Yang X,  Dai J,  Elliott D,  Gawel SH,  Lucht M,  Feng Z,  Marrero JA,  Srivastava S,  Chan DW,  Davis GJ
Clin Proteomics 2019;16:2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30675135
PMC ID: PMC6334458

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Fisher WE,  Cruz-Monserrate Z,  McElhany AL,  Lesinski GB,  Hart PA,  Ghosh R,  Van Buren G,  Fishman DS,  Rinaudo JAS,  Serrano J,  Srivastava S,  Mace T,  Topazian M,  Feng Z,  Yadav D,  Pandol SJ,  Hughes SJ,  Liu RY,  Lu E,  Orr R,  Whitcomb DC,  Abouhamze AS,  Steen H,  Sellers ZM,  Troendle DM,  Uc A,  Lowe ME,  Conwell DL,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1213-1221
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325860
PMC ID: PMC6197069

Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Hart PA,  Andersen DK,  Mather KJ,  Castonguay AC,  Bajaj M,  Bellin MD,  Bradley D,  Contreras N,  Habtezion A,  Korc M,  Kudva Y,  Petrov MS,  Whitcomb DC,  Yadav D,  Yuan Y,  Rinaudo JAS,  Srivastava S,  Serrano J,  Goodarzi MO,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1239-1243
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325863
PMC ID: PMC6195331

A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Maitra A,  Sharma A,  Brand RE,  Van Den Eeden SK,  Fisher WE,  Hart PA,  Hughes SJ,  Mather KJ,  Pandol SJ,  Park WG,  Feng Z,  Serrano J,  Rinaudo JAS,  Srivastava S,  Chari ST,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1244-1248
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325864
PMC ID: PMC6432934

Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality.

Serrano J,  Andersen DK,  Forsmark CE,  Pandol SJ,  Feng Z,  Srivastava S,  Rinaudo JAS,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1208-1212
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325859
PMC ID: PMC6195329

PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Yadav D,  Park WG,  Fogel EL,  Li L,  Chari ST,  Feng Z,  Fisher WE,  Forsmark CE,  Jeon CY,  Habtezion A,  Hart PA,  Hughes SJ,  Othman MO,  Rinaudo JAS,  Pandol SJ,  Tirkes T,  Serrano J,  Srivastava S,  Van Den Eeden SK,  Whitcomb DC,  Topazian M,  Conwell DL,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1229-1238
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325862
PMC ID: PMC6619499

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.

Xiao Q,  Sun Y,  Dobi A,  Srivastava S,  Wang W,  Srivastava S,  Ji Y,  Hou J,  Zhao GP,  Li Y,  Li H
Sci Rep 2018 Aug 27;8(1):12868
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30150711
PMC ID: PMC6110738

The PreCancer Atlas (PCA).

Srivastava S,  Ghosh S,  Kagan J,  Mazurchuk R
Trends Cancer 2018 Aug;4(8):513-514
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30064657
PMC ID: not available

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities.

Srivastava S,  Ghosh S,  Kagan J,  Mazurchuk R,  National Cancer Institute's HTAN Implementation
Trends Cancer 2018 Aug;4(8):523-536
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: 30064661
PMC ID: not available

Cell-based reference samples designed with specific differences in microRNA biomarkers.

Pine PS,  Lund SP,  Stass SA,  Kukuruga D,  Jiang F,  Sorbara L,  Srivastava S,  Salit M
BMC Biotechnol 2018 Mar 20;18(1):17
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29554888
PMC ID: PMC5859499

Summarizing performance for genome scale measurement of miRNA: reference samples and metrics.

Pine PS,  Lund SP,  Parsons JR,  Vang LK,  Mahabal AA,  Cinquini L,  Kelly SC,  Kincaid H,  Crichton DJ,  Spira A,  Liu G,  Gower AC,  Pass HI,  Goparaju C,  Dubinett SM,  Krysan K,  Stass SA,  Kukuruga D,  Van Keuren-Jensen K,  Courtright-Lim A,  Thompson KL,  Rosenzweig BA,  Sorbara L,  Srivastava S,  Salit ML
BMC Genomics 2018 Mar 6;19(1):180
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29510677
PMC ID: PMC5838960

Validation: a critical step in bringing biomarkers to clinical fruition.

Srivastava S,  Kramer BS
Ann Epidemiol 2018 Feb;28(2):135-138
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Office of the Director
PubMed ID: 29157735
PMC ID: not available

Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.

Young MR,  Wagner PD,  Ghosh S,  Rinaudo JA,  Baker SG,  Zaret KS,  Goggins M,  Srivastava S
Pancreas 2018 Feb;47(2):135-141
Major Program(s) or Research Group(s): BiometryCancer Biomarkers
PubMed ID: 29346214
PMC ID: PMC5777224

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.

Wang H,  Barbieri CE,  He J,  Gao Y,  Shi T,  Wu C,  Schepmoes AA,  Fillmore TL,  Chae SS,  Huang D,  Mosquera JM,  Qian WJ,  Smith RD,  Srivastava S,  Kagan J,  Camp DG 2nd,  Rodland KD,  Rubin MA,  Liu T
J Transl Med 2017 Aug 15;15(1):175
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28810879
PMC ID: PMC5557563

A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

Balasenthil S,  Huang Y,  Liu S,  Marsh T,  Chen J,  Stass SA,  KuKuruga D,  Brand R,  Chen N,  Frazier ML,  Jack Lee J,  Srivastava S,  Sen S,  McNeill Killary A
J Natl Cancer Inst 2017 Aug 1;109(8)
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28376184
PMC ID: PMC6059209

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV,  Wang K,  Sheng X,  Bensen JT,  Hazelett DJ,  Cook MB,  Ingles SA,  Kittles RA,  Strom SS,  Rybicki BA,  Nemesure B,  Isaacs WB,  Stanford JL,  Zheng W,  Sanderson M,  John EM,  Park JY,  Xu J,  Stevens VL,  Berndt SI,  Huff CD,  Wang Z,  Yeboah ED,  Tettey Y,  Biritwum RB,  Adjei AA,  Tay E,  Truelove A,  Niwa S,  Sellers TA,  Yamoah K,  Murphy AB,  Crawford DC,  Gapstur SM,  Bush WS,  Aldrich MC,  Cussenot O,  Petrovics G,  Cullen J,  Neslund-Dudas C,  Stern MC,  Jarai ZK,  Govindasami K,  Chokkalingam AP,  Hsing AW,  Goodman PJ,  Hoffmann T,  Drake BF,  Hu JJ,  Clark PE,  Van Den Eeden SK,  Blanchet P,  Fowke JH,  Casey G,  Hennis AJM,  Han Y,  Lubwama A,  Thompson IM Jr,  Leach R,  Easton DF,  Schumacher F,  Van den Berg DJ,  Gundell SM,  Stram A,  Wan P,  Xia L,  Pooler LC,  Mohler JL,  Fontham ETH,  Smith GJ,  Taylor JA,  Srivastava S,  Eeles RA,  Carpten J,  Kibel AS,  Multigner L,  Parent ME,  Menegaux F,  Cancel-Tassin G,  Klein EA,  Brureau L,  Stram DO,  Watya S,  Chanock SJ,  Witte JS,  Blot WJ,  Henderson BE,  Haiman CA,  PRACTICAL/ELLIPSE Consortium
J Natl Cancer Inst 2017 Aug 1;109(8)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29117387
PMC ID: PMC5448553

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG,  Feng Z,  Howard DH,  Tomlins SA,  Sokoll LJ,  Chan DW,  Regan MM,  Groskopf J,  Chipman J,  Patil DH,  Salami SS,  Scherr DS,  Kagan J,  Srivastava S,  Thompson IM Jr,  Siddiqui J,  Fan J,  Joon AY,  Bantis LE,  Rubin MA,  Chinnayian AM,  Wei JT,  and the EDRN-PCA3 Study Group,  Bidair M,  Kibel A,  Lin DW,  Lotan Y,  Partin A,  Taneja S
JAMA Oncol 2017 Aug 1;3(8):1085-1093
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28520829
PMC ID: PMC5710334

Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.

Honda K,  Srivastava S
Biomark Med 2016 Nov;10(11):1197-1207
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27673558
PMC ID: PMC5493967

Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.

Kenner BJ,  Chari ST,  Maitra A,  Srivastava S,  Cleeter DF,  Go VL,  Rothschild LJ,  Goldberg AE
Pancreas 2016 Sep;45(8):1073-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27518362
PMC ID: PMC4993121

Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.

Miller MS,  Allen P,  Brentnall TA,  Goggins M,  Hruban RH,  Petersen GM,  Rao CV,  Whitcomb DC,  Brand RE,  Chari ST,  Klein AP,  Lubman DM,  Rhim AD,  Simeone DM,  Wolpin BM,  Umar A,  Srivastava S,  Steele VE,  Rinaudo JA
Pancreas 2016 Sep;45(8):1080-91
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: 27518363
PMC ID: PMC4988336

Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Srivastava S,  Reid BJ,  Ghosh S,  Kramer BS
J Cell Physiol 2016 Sep;231(9):1870-5
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Office of the Director
PubMed ID: 26505642
PMC ID: PMC5811189

The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.

Wang M,  Devarajan K,  Singal AG,  Marrero JA,  Dai J,  Feng Z,  Rinaudo JA,  Srivastava S,  Evans A,  Hann HW,  Lai Y,  Yang H,  Block TM,  Mehta A
Cancer Prev Res (Phila) 2016 Feb;9(2):172-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26712941
PMC ID: PMC4740237

The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.

Wang H,  Shi T,  Qian WJ,  Liu T,  Kagan J,  Srivastava S,  Smith RD,  Rodland KD,  Camp DG 2nd
Expert Rev Proteomics 2016;13(1):99-114
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26581546
PMC ID: PMC4822694

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

Petrovics G,  Li H,  Stümpel T,  Tan SH,  Young D,  Katta S,  Li Q,  Ying K,  Klocke B,  Ravindranath L,  Kohaar I,  Chen Y,  Ribli D,  Grote K,  Zou H,  Cheng J,  Dalgard CL,  Zhang S,  Csabai I,  Kagan J,  Takeda D,  Loda M,  Srivastava S,  Scherf M,  Seifert M,  Gaiser T,  McLeod DG,  Szallasi Z,  Ebner R,  Werner T,  Sesterhenn IA,  Freedman M,  Dobi A,  Srivastava S
EBioMedicine 2015 Dec;2(12):1957-64
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26844274
PMC ID: PMC4703707

Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.

Honda K,  Kobayashi M,  Okusaka T,  Rinaudo JA,  Huang Y,  Marsh T,  Sanada M,  Sasajima Y,  Nakamori S,  Shimahara M,  Ueno T,  Tsuchida A,  Sata N,  Ioka T,  Yasunami Y,  Kosuge T,  Miura N,  Kamita M,  Sakamoto T,  Shoji H,  Jung G,  Srivastava S,  Yamada T
Sci Rep 2015 Nov 9;5:15921
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26549697
PMC ID: PMC4637825

Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.

Kelly KA,  Hollingsworth MA,  Brand RE,  Liu CH,  Singh VK,  Srivastava S,  Wasan AD,  Yadav D,  Andersen DK
Pancreas 2015 Nov;44(8):1185-94
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26465948
PMC ID: PMC4608388

The Doylestown algorithm - a test to improve the performance of AFP in the detection of early stage hepatocellular carcinoma

Mehta Anand,  Wang Mengjun,  Devarajan Karthik,  Singal Amit G.,  Marrero Jorge A.,  Feng Ziding,  Rinaudo Jo Ann,  Srivastava Sudhir,  Evans Alison,  Hann Hie-Won,  Yang Hushan,  Javaid Asad,  Poongkuran Mugilan,  Lau Daryl,  Block Timothy
Hepatology 2015 Oct;62(Suppl 1):398A-398A
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

ERG-based stratification of prostate cancer highlights ethnicity associated biological differences

Dobi Albert,  Degon Michael,  Farrell James,  Baptiste Wagner,  Young Denise,  Chen Yongmei,  Petrovics Gyorgy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudir,  Rosner Inger,  McLeod David G.,  Srivastava Shiv,  Sesterhenn Isabel
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 5277
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Analytical platform evaluation for quantification of ERG oncoprotein in prostate cancer using protein and mRNA detection methods

He Jintang,  Schepmoes Athena,  Rastogi Anshu,  Tan Shyh-Han,  Yan Wusheng,  Huang Wei,  Banerjee Sreedatta,  Shi Tujin,  Wu Chaochao,  Fillmore Thomas,  Gao Yuqian,  Kagan Jacob,  Srivastava Sudhir,  Smith Richard,  Qian Wei-Jun,  McLeod David,  Petrovics Gyorgy,  Dobi Albert,  Srinivasan Alagarsamy,  Srivastava Shiv,  Rodland Karin,  Liu Tao,  Camp David
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 1818
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Evaluation of prostate cancer biomarkers and therapeutic targets in FFPE specimens using the NanoString platform

Lee Jocelyn,  Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Mohamed Ahmed,  Ravindranath Lakshmi,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David G.,  Sesterhenn Isabell A.,  Srivastava Shiv,  Petrovics Gyorgy
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 2016
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

miRNA reference samples for interlaboratory study

Pine P. Scott,  Sorbara Lynn R.,  Srivastava Sudhir,  Salit Marc
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 3967
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers

Skates Steven J.,  Anderson Karen S.,  Liu Tao,  Kulasingam Vathany,  Rabideau Dustin,  Wu Chaochao,  Gillette Michael,  Godwin Andrew K.,  Urban Nicole,  Lokshin Anna,  Marks Jeffrey,  Diamandis Eleftherios,  Zhang Zhen,  Srivastava Sudhir,  Kagan Jacob,  Patriotis Christos,  Rodland Karin
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 1570
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Early detection of sporadic pancreatic cancer: summative review.

Chari ST,  Kelly K,  Hollingsworth MA,  Thayer SP,  Ahlquist DA,  Andersen DK,  Batra SK,  Brentnall TA,  Canto M,  Cleeter DF,  Firpo MA,  Gambhir SS,  Go VL,  Hines OJ,  Kenner BJ,  Klimstra DS,  Lerch MM,  Levy MJ,  Maitra A,  Mulvihill SJ,  Petersen GM,  Rhim AD,  Simeone DM,  Srivastava S,  Tanaka M,  Vinik AI,  Wong D
Pancreas 2015 Jul;44(5):693-712
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25931254
PMC ID: PMC4467589

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD,  Carrick DM,  Mechanic LE,  Srivastava S,  Anderson GL,  Baron JA,  Berg CD,  Cullen J,  Diamandis EP,  Doria-Rose VP,  Goddard KA,  Hankinson SE,  Kushi LH,  Larson EB,  McShane LM,  Schilsky RL,  Shak S,  Skates SJ,  Urban N,  Kramer BS,  Khoury MJ,  Ransohoff DF
J Natl Cancer Inst 2015 Apr;107(4)
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Office of the Director
PubMed ID: 25688116
PMC ID: PMC4342676

Racial/ethnic variation in a common genetic alteration in prostate cancer

Sesterhenn Isabell,  Young Denise,  Chen Yongmei,  Petrovics Gyorgy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Rosner Inger L.,  McLeod David G.,  Dobi Albert,  Srivastava Shiv
J Clin Oncol 2015 Mar 1;33(Suppl 7):Abstract 14
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.

He J,  Schepmoes AA,  Shi T,  Wu C,  Fillmore TL,  Gao Y,  Smith RD,  Qian WJ,  Rodland KD,  Liu T,  Camp DG 2nd,  Rastogi A,  Tan SH,  Yan W,  Mohamed AA,  Huang W,  Banerjee S,  Kagan J,  Srivastava S,  McLeod DG,  Srivastava S,  Petrovics G,  Dobi A,  Srinivasan A
J Transl Med 2015 Feb 12;13:54
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25889691
PMC ID: PMC4342100

Optimization of Nanostring Platform for Evaluation of Prostate Cancer Biomarkers and Therapeutic Targes in FFPE Specimens

Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Ravindranath Lakshmi,  Lee Jocelyn,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David,  Sesterhenn Isabell,  Srivastava Shiv,  Petrovics Gyorgy
Mod Pathol 2015 Feb;28(Suppl 2):268A-269A
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Optimization of Nanostring Platform for Evaluation of Prostate Cancer Biomarkers and Therapeutic Targes in FFPE Specimens

Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Ravindranath Lakshmi,  Lee Jocelyn,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David,  Sesterhenn Isabell,  Srivastava Shiv,  Petrovics Gyotgy
Lab Invest 2015 Feb;95(Suppl 1):268A-269A, Abstract 1070
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB,  Huang Y,  Balasenthil S,  Partyka K,  Tang H,  Anderson M,  Allen P,  Sasson A,  Zeh H,  Kaul K,  Kletter D,  Ge S,  Bern M,  Kwon R,  Blasutig I,  Srivastava S,  Frazier ML,  Sen S,  Hollingsworth MA,  Rinaudo JA,  Killary AM,  Brand RE
PLoS One 2015;10(10):e0139049
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26431551
PMC ID: PMC4592020

Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection.

Maragh S,  Veltri RW,  Lund SP,  Mangold L,  Isharwal S,  Christudass CS,  Partin AW,  Humphreys EB,  Sorbara L,  Srivastava S,  Wagner PD
Cancer Biomark 2015;15(6):763-73
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26406418
PMC ID: not available

Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis.

Wu TJ,  Schriml LM,  Chen QR,  Colbert M,  Crichton DJ,  Finney R,  Hu Y,  Kibbe WA,  Kincaid H,  Meerzaman D,  Mitraka E,  Pan Y,  Smith KM,  Srivastava S,  Ward S,  Yan C,  Mazumder R
Database (Oxford) 2015;2015:bav032
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25841438
PMC ID: PMC4385274

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

Wei JT,  Feng Z,  Partin AW,  Brown E,  Thompson I,  Sokoll L,  Chan DW,  Lotan Y,  Kibel AS,  Busby JE,  Bidair M,  Lin DW,  Taneja SS,  Viterbo R,  Joon AY,  Dahlgren J,  Kagan J,  Srivastava S,  Sanda MG
J Clin Oncol 2014 Dec 20;32(36):4066-72
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25385735
PMC ID: PMC4265117

Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.

He J,  Sun X,  Shi T,  Schepmoes AA,  Fillmore TL,  Petyuk VA,  Xie F,  Zhao R,  Gritsenko MA,  Yang F,  Kitabayashi N,  Chae SS,  Rubin MA,  Siddiqui J,  Wei JT,  Chinnaiyan AM,  Qian WJ,  Smith RD,  Kagan J,  Srivastava S,  Rodland KD,  Liu T,  Camp DG 2nd
Mol Oncol 2014 Oct;8(7):1169-80
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25266362
PMC ID: PMC4183720

ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity.

Rastogi A,  Tan SH,  Banerjee S,  Sharad S,  Kagan J,  Srivastava S,  McLeod DG,  Srivastava S,  Srinivasan A
Monoclon Antib Immunodiagn Immunother 2014 Aug;33(4):201-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 25170998
PMC ID: not available

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Esserman LJ,  Thompson IM,  Reid B,  Nelson P,  Ransohoff DF,  Welch HG,  Hwang S,  Berry DA,  Kinzler KW,  Black WC,  Bissell M,  Parnes H,  Srivastava S
Lancet Oncol 2014 May;15(6):e234-42
Major Program(s) or Research Group(s): Cancer BiomarkersProstate and Urologic Cancer
PubMed ID: 24807866
PMC ID: PMC4322920

A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum.

Shi T,  Gao Y,  Quek SI,  Fillmore TL,  Nicora CD,  Su D,  Zhao R,  Kagan J,  Srivastava S,  Rodland KD,  Liu T,  Smith RD,  Chan DW,  Camp DG 2nd,  Liu AY,  Qian WJ
J Proteome Res 2014 Feb 7;13(2):875-82
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 24251762
PMC ID: PMC3975687

A Laboratory-targeted, Data Management and Processing System for the Early Detection Research Network

Verma Rishi,  Hart Andrew F.,  Mattmann Chris A.,  Crichton Daniel J.,  Kincaid Heather,  Kelly Sean C.,  Joyce Michael J.,  Zimdars Paul,  Tabb David L.,  Holman Jay D.,  Chambers Matthew,  Anton Kristen,  Colbert Maureen,  Patriotis Christos,  Srivastava Sudhir
2014 IEEE 27th International Symposium on Computer-Based Medical Systems (CBMS) 2014 :401-405
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.

Shi T,  Fillmore TL,  Gao Y,  Zhao R,  He J,  Schepmoes AA,  Nicora CD,  Wu C,  Chambers JL,  Moore RJ,  Kagan J,  Srivastava S,  Liu AY,  Rodland KD,  Liu T,  Camp DG 2nd,  Smith RD,  Qian WJ
Anal Chem 2013 Oct 1;85(19):9196-203
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 24004026
PMC ID: PMC3839867

The word "cancer": how language can corrupt thought.

Dunn BK,  Srivastava S,  Kramer BS
BMJ 2013 Sep 10;347:f5328
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 24022035
PMC ID: not available

Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.

Vydelingum NA,  Sorbara L,  Wagner P,  Srivastava S
Expert Rev Mol Diagn 2013 Jun;13(5):421-3
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 23782249
PMC ID: not available

The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.

Feng Z,  Kagan J,  Pepe M,  Thornquist M,  Ann Rinaudo J,  Dahlgren J,  Krueger K,  Zheng Y,  Patriotis C,  Huang Y,  Sorbara L,  Thompson I,  Srivastava S
Clin Chem 2013 Jan;59(1):68-74
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 23193062
PMC ID: PMC3652317

The early detection research network: 10-year outlook.

Srivastava S
Clin Chem 2013 Jan;59(1):60-7
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 23160065
PMC ID: not available

A simple packed bed device for antibody labelled rare cell capture from whole blood.

Kralj JG,  Arya C,  Tona A,  Forbes TP,  Munson MS,  Sorbara L,  Srivastava S,  Forry SP
Lab Chip 2012 Dec 7;12(23):4972-5
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 23079718
PMC ID: not available

One hundred sixty-four consecutive beating heart totally endoscopic coronary artery bypass cases without intraoperative conversion.

Srivastava S,  Barrera R,  Quismundo S
Ann Thorac Surg 2012 Nov;94(5):1463-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22771485
PMC ID: not available

Systematic, evidence-based discovery of biomarkers at the NCI.

Prensner JR,  Chinnaiyan AM,  Srivastava S
Clin Exp Metastasis 2012 Oct;29(7):645-52
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22868876
PMC ID: PMC3679913

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.

Liu T,  Hossain M,  Schepmoes AA,  Fillmore TL,  Sokoll LJ,  Kronewitter SR,  Izmirlian G,  Shi T,  Qian WJ,  Leach RJ,  Thompson IM,  Chan DW,  Smith RD,  Kagan J,  Srivastava S,  Rodland KD,  Camp DG 2nd
J Proteomics 2012 Aug 3;75(15):4747-57
Major Program(s) or Research Group(s): Cancer BiomarkersBiometry
PubMed ID: 22846433
PMC ID: PMC3410652

Systematic, evidence-based discovery of biomarkers at the National Cancer Institute.

Srivastava S,  Patriotis C
Int J Gynecol Cancer 2012 May;22 Suppl 1:S41
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22543920
PMC ID: not available

New paradigms in translational science research in cancer biomarkers.

Wagner PD,  Srivastava S
Transl Res 2012 Apr;159(4):343-53
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22424436
PMC ID: PMC3478674

Biomarkers in public health.

Srivastava S
Cancer Biomark 2012;10(1):1-2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22297546
PMC ID: not available

Scientific frontiers: emerging technologies for salivary diagnostics.

Baum BJ,  Yates JR 3rd,  Srivastava S,  Wong DT,  Melvin JE
Adv Dent Res 2011 Oct;23(4):360-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 21917746
PMC ID: PMC3172997

The human proteome project: current state and future direction.

Legrain P,  Aebersold R,  Archakov A,  Bairoch A,  Bala K,  Beretta L,  Bergeron J,  Borchers CH,  Corthals GL,  Costello CE,  Deutsch EW,  Domon B,  Hancock W,  He F,  Hochstrasser D,  Marko-Varga G,  Salekdeh GH,  Sechi S,  Snyder M,  Srivastava S,  Uhlén M,  Wu CH,  Yamamoto T,  Paik YK,  Omenn GS
Mol Cell Proteomics 2011 Jul;10(7):M111.009993
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 21742803
PMC ID: PMC3134076

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Cramer DW,  Bast RC Jr,  Berg CD,  Diamandis EP,  Godwin AK,  Hartge P,  Lokshin AE,  Lu KH,  McIntosh MW,  Mor G,  Patriotis C,  Pinsky PF,  Thornquist MD,  Scholler N,  Skates SJ,  Sluss PM,  Srivastava S,  Ward DC,  Zhang Z,  Zhu CS,  Urban N
Cancer Prev Res (Phila) 2011 Mar;4(3):365-74
Major Program(s) or Research Group(s): Early DetectionCancer BiomarkersProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21372036
PMC ID: PMC3085251

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Zhu CS,  Pinsky PF,  Cramer DW,  Ransohoff DF,  Hartge P,  Pfeiffer RM,  Urban N,  Mor G,  Bast RC Jr,  Moore LE,  Lokshin AE,  McIntosh MW,  Skates SJ,  Vitonis A,  Zhang Z,  Ward DC,  Symanowski JT,  Lomakin A,  Fung ET,  Sluss PM,  Scholler N,  Lu KH,  Marrangoni AM,  Patriotis C,  Srivastava S,  Buys SS,  Berg CD,  PLCO Project Team
Cancer Prev Res (Phila) 2011 Mar;4(3):375-83
Major Program(s) or Research Group(s): Early DetectionCancer BiomarkersBiometryProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 21372037
PMC ID: PMC3057372

Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation.

Atha DH,  Manne U,  Grizzle WE,  Wagner PD,  Srivastava S,  Reipa V
J Histochem Cytochem 2010 Nov;58(11):1005-14
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 20805583
PMC ID: PMC2958133

A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.

Sokoll LJ,  Sanda MG,  Feng Z,  Kagan J,  Mizrahi IA,  Broyles DL,  Partin AW,  Srivastava S,  Thompson IM,  Wei JT,  Zhang Z,  Chan DW
Cancer Epidemiol Biomarkers Prev 2010 May;19(5):1193-200
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 20447916
PMC ID: PMC2867076

Strategic approach to validating methylated genes as biomarkers for breast cancer.

Wang W,  Srivastava S
Cancer Prev Res (Phila) 2010 Jan;3(1):16-24
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 20051369
PMC ID: not available

Developing recombinant antibodies for biomarker detection.

Baird CL,  Fischer CJ,  Pefaur NB,  Miller KD,  Kagan J,  Srivastava S,  Rodland KD
Cancer Biomark 2010;6(5-6):271-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 20938087
PMC ID: not available

The biology of incipient, pre-invasive or intraepithelial neoplasia.

Grizzle WE,  Srivastava S,  Manne U
Cancer Biomark 2010;9(1-6):21-39
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22112468
PMC ID: PMC3430522

Translational pathology of neoplasia.

Grizzle WE,  Srivastava S,  Manne U
Cancer Biomark 2010;9(1-6):7-20
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22112467
PMC ID: PMC3445029

Molecular Detection and Diagnosis of Cancer.

Patriotis C,  Maruvada P,  Srivastava S
2010
The Molecular Basis of Human Cancer
ISBN: not available
Major Program(s) or Research Group(s): Cancer Biomarkers

Biomarkers and the genetics of early neoplastic lesions.

Srivastava S,  Grizzle WE
Cancer Biomark 2010;9(1-6):41-64
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22112469
PMC ID: PMC3478673

Translational pathology of early cancer.

Srivastava S,  Grizzle WE
Cancer Biomark 2010;9(1-6):1-4
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22112466
PMC ID: not available

Noncoding RNAs in molecular characterization of cancer preneoplasia.

Wang W,  Srivastava S
Cancer Biomark 2010;9(1-6):133-40
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 22112473
PMC ID: not available

Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells.

Xiao Y,  Gao X,  Taratula O,  Treado S,  Urbas A,  Holbrook RD,  Cavicchi RE,  Avedisian CT,  Mitra S,  Savla R,  Wagner PD,  Srivastava S,  He H
BMC Cancer 2009 Oct 2;9:351
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 19799784
PMC ID: PMC2764730

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA,  Feng Z,  Wang Y,  Nguyen MH,  Befeler AS,  Roberts LR,  Reddy KR,  Harnois D,  Llovet JM,  Normolle D,  Dalhgren J,  Chia D,  Lok AS,  Wagner PD,  Srivastava S,  Schwartz M
Gastroenterology 2009 Jul;137(1):110-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 19362088
PMC ID: PMC2704256

A compendium of potential biomarkers of pancreatic cancer.

Harsha HC,  Kandasamy K,  Ranganathan P,  Rani S,  Ramabadran S,  Gollapudi S,  Balakrishnan L,  Dwivedi SB,  Telikicherla D,  Selvan LD,  Goel R,  Mathivanan S,  Marimuthu A,  Kashyap M,  Vizza RF,  Mayer RJ,  Decaprio JA,  Srivastava S,  Hanash SM,  Hruban RH,  Pandey A
PLoS Med 2009 Apr 7;6(4):e1000046
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 19360088
PMC ID: PMC2661257

Diagnostics other than blood.

Srivastava S,  Krueger KE
2008 November
Wong D
Saliva Diagnostics
ISBN: 978-0-8138-1333-2
Major Program(s) or Research Group(s): Cancer Biomarkers

Performance of mitochondrial DNA mutations detecting early stage cancer.

Jakupciak JP,  Maragh S,  Markowitz ME,  Greenberg AK,  Hoque MO,  Maitra A,  Barker PE,  Wagner PD,  Rom WN,  Srivastava S,  Sidransky D,  O'Connell CD
BMC Cancer 2008 Oct 3;8:285
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18834532
PMC ID: PMC2572633

Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.

Srivastava S,  Gray JW,  Reid BJ,  Grad O,  Greenwood A,  Hawk ET,  Translational Research Working Group
Clin Cancer Res 2008 Sep 15;14(18):5672-7
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18794074
PMC ID: PMC2737183

Immobilization strategies for single-chain antibody microarrays.

Seurynck-Servoss SL,  Baird CL,  Miller KD,  Pefaur NB,  Gonzalez RM,  Apiyo DO,  Engelmann HE,  Srivastava S,  Kagan J,  Rodland KD,  Zangar RC
Proteomics 2008 Jun;8(11):2199-210
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18452230
PMC ID: not available

Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection.

Xiao Y,  Gao X,  Gannot G,  Emmert-Buck MR,  Srivastava S,  Wagner PD,  Amos MD,  Barker PE
Int J Cancer 2008 May 15;122(10):2178-86
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18214859
PMC ID: not available

Move over proteomics, here comes glycomics.

Srivastava S
J Proteome Res 2008 May;7(5):1799
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18509903
PMC ID: not available

Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0.

Jakupciak JP,  Maggrah A,  Maragh S,  Maki J,  Reguly B,  Maki K,  Wittock R,  Robinson K,  Wagner PD,  Thayer RE,  Gehman K,  Gehman T,  Srivastava S,  Ngom A,  Dakubo GD,  Parr RL
BMC Cancer 2008 Apr 10;8:95
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18402686
PMC ID: PMC2375897

Biomarkers in oncology research and treatment: early detection research network: a collaborative approach.

Moncada V,  Srivastava S
Biomark Med 2008 Apr;2(2):181-95
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 20477439
PMC ID: not available

Multiple strand displacement amplification of mitochondrial DNA from clinical samples.

Maragh S,  Jakupciak JP,  Wagner PD,  Rom WN,  Sidransky D,  Srivastava S,  O'Connell CD
BMC Med Genet 2008 Feb 7;9:7
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18257929
PMC ID: PMC2268916

Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens.

Maki J,  Robinson K,  Reguly B,  Alexander J,  Wittock R,  Aguirre A,  Diamandis EP,  Escott N,  Skehan A,  Prowse O,  Thayer RE,  Froberg MK,  Wilson MJ,  Maragh S,  Jakupciak JP,  Wagner PD,  Srivastava S,  Dakubo GD,  Parr RL
Am J Clin Pathol 2008 Jan;129(1):57-66
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18089489
PMC ID: not available

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

McLerran D,  Grizzle WE,  Feng Z,  Bigbee WL,  Banez LL,  Cazares LH,  Chan DW,  Diaz J,  Izbicka E,  Kagan J,  Malehorn DE,  Malik G,  Oelschlager D,  Partin A,  Randolph T,  Rosenzweig N,  Srivastava SSrivastava S,  Thompson IM,  Thornquist M,  Troyer D,  Yasui Y,  Zhang Z,  Zhu L,  Semmes OJ
Clin Chem 2008 Jan;54(1):44-52
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17981926
PMC ID: PMC3354530

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.

McLerran D,  Grizzle WE,  Feng Z,  Thompson IM,  Bigbee WL,  Cazares LH,  Chan DW,  Dahlgren J,  Diaz J,  Kagan J,  Lin DW,  Malik G,  Oelschlager D,  Partin A,  Randolph TW,  Sokoll L,  Srivastava SSrivastava S,  Thornquist M,  Troyer D,  Wright GL,  Zhang Z,  Zhu L,  Semmes OJ
Clin Chem 2008 Jan;54(1):53-60
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18024530
PMC ID: PMC4332515

The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.

Block TM,  Marrero J,  Gish RG,  Sherman M,  London WT,  Srivastava S,  Wagner PD
Cancer Biomark 2008;4(1):19-33
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 18334731
PMC ID: not available

Biomarkers at a Crossroads: Implications for Early Cancer Detection & Diagnosis

Srivastava S
2008
IARC World Cancer Report, Section 3: Mechanism of Carcinogenesis
ISBN: not available
Major Program(s) or Research Group(s): Cancer Biomarkers

Biomarkers for prostate cancer detection.

Parekh DJ,  Ankerst DP,  Troyer D,  Srivastava S,  Thompson IM
J Urol 2007 Dec;178(6):2252-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17936845
PMC ID: not available

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.

Kagan J,  Srivastava S,  Barker PE,  Belinsky SA,  Cairns P
Cancer Res 2007 May 15;67(10):4545-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17510378
PMC ID: not available

Cancer genetics in the post genomic era.

Srivastava S
Curr Mol Med 2007 Feb;7(1):1-2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17311528
PMC ID: not available

Risk-based and diagnostics-linked personalized medicine for cancer.

Srivastava S,  Wagner PD
Pers Med 2007 Feb;4(1)
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Workshop on imaging science development for cancer prevention and preemption.

Kelloff GJ,  Sullivan DC,  Baker H,  Clarke LP,  Nordstrom R,  Tatum JL,  Dorfman GS,  Jacobs P,  Berg CD,  Pomper MG,  Birrer MJ,  Tempero M,  Higley HR,  Petty BG,  Sigman CC,  Maley C,  Sharma P,  Wax A,  Ginsberg GG,  Dannenberg AJ,  Hawk ET,  Messing EM,  Grossman HB,  Harisinghani M,  Bigio IJ,  Griebel D,  Henson DE,  Fabian CJ,  Ferrara K,  Fantini S,  Schnall MD,  Zujewski JA,  Hayes W,  Klein EA,  DeMarzo A,  Ocak I,  Ketterling JA,  Tempany C,  Shtern F,  Parnes HL,  Gomez J,  Srivastava S,  Szabo E,  Lam S,  Seibel EJ,  Massion P,  McLennan G,  Cleary K,  Suh R,  Burt RW,  Pfeiffer RM,  Hoffman JM,  Roy HK,  Wang T,  Limburg PJ,  El-Deiry WS,  Papadimitrakopoulou V,  Hittelman WN,  MacAulay C,  Veltri RW,  Solomon D,  Jeronimo J,  Richards-Kortum R,  Johnson KA,  Viner JL,  Stratton SP,  Rajadhyaksha M,  Dhawan A,  Workshop Program Committee
Cancer Biomark 2007;3(1):1-33
Major Program(s) or Research Group(s): Lung and Upper Aerodigestive CancerBreast and Gynecologic CancerProstate and Urologic Cancer
PubMed ID: 17655039
PMC ID: not available

Biomarkers.

Krueger KE,  Srivastava S
2007
Rom WN
Environmental and Occupational Medicine
ISBN: not available
Major Program(s) or Research Group(s): Cancer Biomarkers

Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.

Srivastava S
Gastrointest Cancer Res 2007;1(4 Suppl 2):S60-3
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 19360150
PMC ID: PMC2666843

Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics.

Krueger KE,  Srivastava S
Mol Cell Proteomics 2006 Oct;5(10):1799-810
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16844681
PMC ID: not available

Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.

Barker PE,  Wagner PD,  Stein SE,  Bunk DM,  Srivastava S,  Omenn GS
Clin Chem 2006 Sep;52(9):1669-74
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16840585
PMC ID: not available

Joint National Cancer Institute-Food and Drug Administration workshop on research strategies, study designs, and statistical approaches to biomarker validation for cancer diagnosis and detection.

Maruvada P,  Srivastava S
Cancer Epidemiol Biomarkers Prev 2006 Jun;15(6):1078-82
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16775163
PMC ID: not available

Robotic assistance in cardiac surgery.

Srivastava S,  Barrera R,  Quismundo S
Indian Heart J 2006 May-Jun;58(3):196-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 19033614
PMC ID: not available

Molecular screening of cancer: the future is here.

Srivastava S
Mol Diagn Ther 2006;10(4):221-30
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16884325
PMC ID: not available

Preparation and characterization of candidate reference materials for telomerase assays.

Jakupciak JP,  Barker PE,  Wang W,  Srivastava S,  Atha DH
Clin Chem 2005 Aug;51(8):1443-50
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15951318
PMC ID: not available

Recent advances in biomarkers for cancer diagnosis and treatment.

Manne U,  Srivastava RG,  Srivastava S
Drug Discov Today 2005 Jul 15;10(14):965-76
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16023055
PMC ID: not available

Proteomics in the forefront of cancer biomarker discovery.

Srivastava S,  Srivastava RG
J Proteome Res 2005 Jul-Aug;4(4):1098-103
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16083258
PMC ID: not available

Proteomic maps of the cancer-associated infectious agents.

Srivastava S,  Verma M,  Gopal-Srivastava R
J Proteome Res 2005 Jul-Aug;4(4):1171-80
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16083267
PMC ID: not available

Mitochondrial DNA as a cancer biomarker.

Jakupciak JP,  Wang W,  Markowitz ME,  Ally D,  Coble M,  Srivastava S,  Maitra A,  Barker PE,  Sidransky D,  O'Connell CD
J Mol Diagn 2005 May;7(2):258-67
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15858150
PMC ID: PMC1867534

Biomarkers in molecular medicine: cancer detection and diagnosis.

Maruvada P,  Wang W,  Wagner PD,  Srivastava S
Biotechniques 2005 Apr;Suppl:9-15
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16528918
PMC ID: not available

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

Semmes OJ,  Feng Z,  Adam BL,  Banez LL,  Bigbee WL,  Campos D,  Cazares LH,  Chan DW,  Grizzle WE,  Izbicka E,  Kagan J,  Malik G,  McLerran D,  Moul JW,  Partin A,  Prasanna P,  Rosenzweig J,  Sokoll LJ,  Srivastava SSrivastava S,  Thompson I,  Welsh MJ,  White N,  Winget M,  Yasui Y,  Zhang Z,  Zhu L
Clin Chem 2005 Jan;51(1):102-12
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15613711
PMC ID: not available

Cancer biomarkers. Preface.

Dixit R,  Srivastava S
Cancer Biomark 2005;1(1):3-4
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17203571
PMC ID: not available

Mitochondria as a target for early detection and diagnosis of cancer.

Kagan J,  Srivastava S
Crit Rev Clin Lab Sci 2005;42(5-6):453-72
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16390681
PMC ID: not available

Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer.

Srivastava S
Dis Markers 2005;21(1):1-2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15735317
PMC ID: PMC3850838

Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer.

Srivastava S
Cancer Biomark 2005;1(1):1-2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 17192027
PMC ID: not available

The Promise of Proteomics: Biology, Applications and Challenge.

Wagner PD,  Srivastava S
2005
Srivastava S
Informatics and Proteomics
ISBN: 9781420027624
Major Program(s) or Research Group(s): Cancer Biomarkers

Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.

Jakupciak JP,  Wang W,  Barker PE,  Srivastava S,  Atha DH
J Mol Diagn 2004 Aug;6(3):157-65
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15269291
PMC ID: PMC1867633

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.

Grizzle WE,  Semmes OJ,  Basler J,  Izbicka E,  Feng Z,  Kagan J,  Adam BL,  Troyer D,  Srivastava S,  Thornquist M,  Zhang Z,  Thompson IM
Urol Oncol 2004 Jul-Aug;22(4):337-43
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15283893
PMC ID: not available

Molecular diagnostics: a new frontier in cancer prevention.

Wagner PD,  Maruvada P,  Srivastava S
Expert Rev Mol Diagn 2004 Jul;4(4):503-11
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15225098
PMC ID: not available

Biomarkers for cancer diagnosis: implications for nutritional research.

Maruvada P,  Srivastava S
J Nutr 2004 Jun;134(6 Suppl):1640S-1672S
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15173444
PMC ID: not available

Challenges for biomarkers in cancer detection.

Wagner PD,  Verma M,  Srivastava S
Ann N Y Acad Sci 2004 Jun;1022:9-16
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15251933
PMC ID: not available

Data standards for proteomics: mitochondrial two-dimensional polyacrylamide gel electrophoresis data as a model system.

Ravichandran V,  Vasquez GB,  Srivastava S,  Verma M,  Petricoin E,  Lubell J,  Sriram RD,  Barker PE,  Gilliland GL
Mitochondrion 2004 May;3(6):327-36
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 16120364
PMC ID: not available

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Umar A,  Boland CR,  Terdiman JP,  Syngal S,  de la Chapelle A,  Rüschoff J,  Fishel R,  Lindor NM,  Burgart LJ,  Hamelin R,  Hamilton SR,  Hiatt RA,  Jass J,  Lindblom A,  Lynch HT,  Peltomaki P,  Ramsey SD,  Rodriguez-Bigas MA,  Vasen HF,  Hawk ET,  Barrett JC,  Freedman AN,  Srivastava S
J Natl Cancer Inst 2004 Feb 18;96(4):261-8
Major Program(s) or Research Group(s): Gastrointestinal and Other Cancers
PubMed ID: 14970275
PMC ID: PMC2933058

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.

Grizzle WE,  Adam BL,  Bigbee WL,  Conrads TP,  Carroll C,  Feng Z,  Izbicka E,  Jendoubi M,  Johnsey D,  Kagan J,  Leach RJ,  McCarthy DB,  Semmes OJ,  Srivastava SSrivastava S,  Thompson IM,  Thornquist MD,  Verma M,  Zhang Z,  Zou Z
Dis Markers 2004;19(4-5):185-95
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15258333
PMC ID: PMC3850865

The promise of biomarkers in colorectal cancer detection.

Umar A,  Srivastava S
Dis Markers 2004;20(2):87-96
Major Program(s) or Research Group(s): Gastrointestinal and Other Cancers
PubMed ID: 15322316
PMC ID: PMC3839323

Proteomics in diagnostics.

Veenstra TD,  Srivastava S
Dis Markers 2004;19(4-5):167-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15258331
PMC ID: PMC3850560

Current approaches in mitochondrial proteomics.

Verma M,  Maruvada P,  Srivastava S
2004
Mito Matters
ISBN: not available
Major Program(s) or Research Group(s): Cancer Biomarkers

Epigenetics and cancer.

Verma M,  Maruvada P,  Srivastava S
Crit Rev Clin Lab Sci 2004;41(5-6):585-607
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 15603512
PMC ID: not available

Nutritional links to plausible mechanisms underlying pancreatic cancer: a conference report.

Hine RJ,  Srivastava S,  Milner JA,  Ross SA
Pancreas 2003 Nov;27(4):356-66
Major Program(s) or Research Group(s): Nutritional Science
PubMed ID: 14576500
PMC ID: not available

Proteomic analysis of cancer-cell mitochondria.

Verma M,  Kagan J,  Sidransky D,  Srivastava S
Nat Rev Cancer 2003 Oct;3(10):789-95
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 14570046
PMC ID: not available

High-throughput analysis of telomerase by capillary electrophoresis.

Atha DH,  Miller K,  Sanow AD,  Xu J,  Hess JL,  Wu OC,  Wang W,  Srivastava S,  Highsmith WE
Electrophoresis 2003 Jan;24(1-2):109-14
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12652580
PMC ID: not available

New cancer biomarkers deriving from NCI early detection research.

Verma M,  Srivastava S
Recent Results Cancer Res 2003;163:72-6
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12903844
PMC ID: not available

Epigenetics in cancer: implications for early detection and prevention.

Verma M,  Srivastava S
Lancet Oncol 2002 Dec;3(12):755-63
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12473517
PMC ID: not available

Proteomics for cancer biomarker discovery.

Srinivas PR,  Verma M,  Zhao Y,  Srivastava S
Clin Chem 2002 Aug;48(8):1160-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12142368
PMC ID: not available

Biomarkers in cancer screening: a public health perspective.

Srivastava S,  Gopal-Srivastava R
J Nutr 2002 Aug;132(8 Suppl):2471S-2475S
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12163714
PMC ID: not available

The promise of biomarkers in cancer screening and detection.

Negm RS,  Verma M,  Srivastava S
Trends Mol Med 2002 Jun;8(6):288-93
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12067615
PMC ID: not available

Nanotechnology in early detection of cancer.

Srinivas PR,  Barker P,  Srivastava S
Lab Invest 2002 May;82(5):657-62
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12004006
PMC ID: not available

Markers for early detection of cancer: statistical guidelines for nested case-control studies.

Baker SG,  Kramer BS,  Srivastava S
BMC Med Res Methodol 2002;2:4
Major Program(s) or Research Group(s): Biometry
PubMed ID: 11914137
PMC ID: PMC100327

Nanotechnology: Emerging Developments and Early Detection of Cancer. A two-day workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30-31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA.

Zullo SJ,  Srivastava S,  Looney JP,  Barker PE
Dis Markers 2002;18(4):153-8
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 12590168
PMC ID: PMC3851337

Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect.

Kopelovich L,  Henson DE,  Gazdar AF,  Dunn B,  Srivastava S,  Kelloff GJ,  Greenwald P
Clin Cancer Res 1999 Dec;5(12):3899-905
Major Program(s) or Research Group(s): Chemopreventive Agent Development
PubMed ID: 10632318
PMC ID: not available